EUVIMEDEUVIMED entdecken
Vergleichsstudie

Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

Tingdong Li iD, Fugui Li, Xiaoyi Guo, Congming Hong, Xia Yu, Biaohua Wu, Shifeng Lian, Liuwei Song, Jiabao Tang, Shunhua Wen, Kaimin Gao, Mengling Hao und 13 weitere

New England Journal of Medicine · 31.08.2023 · 389 (9) · 808-819

DOI: 10.1056/nejmoa2301496 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift New England Journal of Medicine, erschienen am 31.08.2023. Verfasst von Tingdong Li und 24 weiteren Autor:innen. Beteiligte Einrichtung: From the State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, …. Hauptthemen laut MEDLINE: Antibodies, Viral, Early Detection of Cancer, Herpesvirus 4, Human, Nasopharyngeal Carcinoma. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Fujian Provincial Department of Science and Technology, Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralEarly Detection of CancerHerpesvirus 4, HumanNasopharyngeal CarcinomaNasopharyngeal NeoplasmsViral ProteinsHumansCase-Control StudiesImmunoglobulin AMass ScreeningProspective StudiesRetrospective StudiesBiomarkersEpitopes

Substanzen

Antibodies, ViralImmunoglobulin ABiomarkersViral ProteinsEpitopes

Autor:innen und Institutionen

  • From the State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutic…

ORCID-Profile: Tingdong Li, Honglin Chen

Förderung

  • Fujian Provincial Department of Science and Technology
  • Ministry of Education of the People's Republic of China
  • Ministry of Science and Technology of the People's Republic of China
  • Ministry of Education of the People’s Republic of China
  • Ministry of Science and Technology of the People’s Republic of China

Zitieren

APA

Li, T., Li, F., Guo, X., Hong, C., Yu, X., Wu, B., Lian, S., Song, L., Tang, J., Wen, S., Gao, K., Hao, M., Cheng, W., Su, Y., Zhang, S., Huang, S., Fang, M., Wang, Y., Ng, M. H., …, & Ji, M. (2023). Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer. New England Journal of Medicine, 389(9), 808-819. https://doi.org/10.1056/nejmoa2301496

Vancouver

Li T, Li F, Guo X, Hong C, Yu X, Wu B, et al. Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer. New England Journal of Medicine. 2023;389(9):808-819. doi:10.1056/nejmoa2301496

BibTeX
@article{Li2023,
  author = {Li, Tingdong and Li, Fugui and Guo, Xiaoyi and Hong, Congming and Yu, Xia and Wu, Biaohua and Lian, Shifeng and Song, Liuwei and Tang, Jiabao and Wen, Shunhua and Gao, Kaimin and Hao, Mengling and Cheng, Weimin and Su, Yingying and Zhang, Shiyin and Huang, Shoujie and Fang, Mujin and Wang, Yingbin and Ng, Mun-Hon and Chen, Honglin and Luo, Wenxin and Ge, Shengxiang and Zhang, Jun and Xia, Ningshao and Ji, Mingfang},
  title = {Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {9},
  pages = {808--819},
  doi = {10.1056/nejmoa2301496}
}
Kostenlos starten →